X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
oncology (12) 12
humans (11) 11
chemotherapy (9) 9
male (9) 9
aged (8) 8
bladder cancer (8) 8
cancer (7) 7
female (7) 7
middle aged (7) 7
aged, 80 and over (6) 6
clinical trials (6) 6
metastasis (6) 6
treatment outcome (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
bladder-cancer (5) 5
carcinoma (5) 5
carcinoma, transitional cell - drug therapy (5) 5
cisplatin (5) 5
article (4) 4
care and treatment (4) 4
neoplasm metastasis (4) 4
urinary bladder neoplasms - drug therapy (4) 4
urologic neoplasms - drug therapy (4) 4
urothelial carcinoma (4) 4
abridged index medicus (3) 3
adult (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biomarkers (3) 3
cisplatin - administration & dosage (3) 3
cystectomy (3) 3
docetaxel (3) 3
drug administration schedule (3) 3
gemcitabine (3) 3
metastatic (3) 3
neoadjuvant chemotherapy (3) 3
neoadjuvant therapy - methods (3) 3
neoplasm invasiveness (3) 3
patients (3) 3
prostate cancer (3) 3
randomized-trial (3) 3
research (3) 3
survival (3) 3
tumors (3) 3
urothelial cancer (3) 3
abiraterone (2) 2
androstenes - administration & dosage (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
biomarkers, tumor - analysis (2) 2
cancer therapies (2) 2
carcinoma, transitional cell - chemistry (2) 2
carcinoma, transitional cell - pathology (2) 2
ctla-4 blockade (2) 2
disease-free survival (2) 2
double-blind (2) 2
doxorubicin (2) 2
enzalutamide (2) 2
gene expression (2) 2
granulocyte colony-stimulating factor - therapeutic use (2) 2
immunotherapy (2) 2
infusions, intravenous (2) 2
internal medicine (2) 2
kaplan-meier estimate (2) 2
ligands (2) 2
long-term-survival (2) 2
medical colleges (2) 2
medicine, general & internal (2) 2
men (2) 2
methotrexate (2) 2
mitoxantrone (2) 2
multicenter (2) 2
mutation (2) 2
neoplasm staging (2) 2
open-label (2) 2
pembrolizumab (2) 2
prospective studies (2) 2
prostatic neoplasms, castration-resistant - drug therapy (2) 2
protective agents - therapeutic use (2) 2
radical cystectomy (2) 2
response evaluation criteria in solid tumors (2) 2
safety (2) 2
single-arm (2) 2
survival analysis (2) 2
trends (2) 2
trial (2) 2
urinary bladder neoplasms - chemistry (2) 2
urinary bladder neoplasms - pathology (2) 2
urology & nephrology (2) 2
vinblastine (2) 2
27 hsp27 (1) 1
abiraterone acetate (1) 1
accuracy (1) 1
acquired-resistance (1) 1
active surveillance (1) 1
administration, intravenous (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 4529 - 4529
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 4532 - 4532
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 101 - 101
101 Background: At our institution, based upon the AUA/ASTRO guidelines, discussion of adjuvant radiation therapy (ART) for patients with adverse pathologic... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. TPS385 - TPS385
TPS385 Background: PARP1 is a key regulator of the transition to lethal castrate resistant prostate cancer (CRPC); niraparib is a potent and selective PARP-1... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 4518 - 4518
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 2_suppl, pp. 187 - 187
187 Background: Neuroendocrine carcinoma of the prostate (NCAP) is an aggressive high grade malignancy that often presents as metastatic disease. Current... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. TPS384 - TPS384
TPS384 Background: Current data suggests RB function is often attenuated in tumors through hyperphosphorylation; thus, RB activity can be “re-awakened” in RB+... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. TPS4585 - TPS4585
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. e593 - e593
e593 Background: The use of radium-223 in patients with metastatic castration-resistant prostate cancer (mCRPC) improves overall survival (OS) and quality of... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 518 - 518
518 Background: Preclinical data suggest there are synergistic effects of radiation therapy (RT) and check point inhibitors in anticancer immunity. The primary... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 350 - 350
350 Background: Small cell neuroendocrine carcinoma of the bladder (SCCB) is rare but aggressive form of genitourinary cancer that can arise de novo or in... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.